136 related articles for article (PubMed ID: 14561176)
1. CCR3 and CXCR3 as drug targets for allergy: principles and potential.
Gangur V; Birmingham NP; Thanesvorakul S; Joseph S
Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):53-62. PubMed ID: 14561176
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
Elsner J; Escher SE; Forssmann U
Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
[TBL] [Abstract][Full Text] [Related]
3. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.
Erin EM; Williams TJ; Barnes PJ; Hansel TT
Curr Drug Targets Inflamm Allergy; 2002 Jun; 1(2):201-14. PubMed ID: 14561201
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in allergy.
Chantry D; Burgess LE
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):109-16. PubMed ID: 14561210
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in CCR3 antagonists.
De Lucca GV
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):516-24. PubMed ID: 16889234
[TBL] [Abstract][Full Text] [Related]
6. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptors in allergic diseases.
Castan L; Magnan A; Bouchaud G
Allergy; 2017 May; 72(5):682-690. PubMed ID: 27864967
[TBL] [Abstract][Full Text] [Related]
8. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.
Amerio P; Frezzolini A; Feliciani C; Verdolini R; Teofoli P; De Pità O; Puddu P
Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):81-94. PubMed ID: 14561178
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation.
Xie JH; Nomura N; Lu M; Chen SL; Koch GE; Weng Y; Rosa R; Di Salvo J; Mudgett J; Peterson LB; Wicker LS; DeMartino JA
J Leukoc Biol; 2003 Jun; 73(6):771-80. PubMed ID: 12773510
[TBL] [Abstract][Full Text] [Related]
11. CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients.
Sénéchal S; Fahy O; Gentina T; Vorng H; Capron M; Walls AF; McEuen AR; Buckley MG; Hamid Q; Wallaert B; Tonnel AB; Tsicopoulos A
Lab Invest; 2002 Jul; 82(7):929-39. PubMed ID: 12118095
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.
Casas R; Lindau C; Zetterström O; Duchén K
Scand J Immunol; 2008 Sep; 68(3):351-61. PubMed ID: 18782262
[TBL] [Abstract][Full Text] [Related]
13. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop.
Campbell JD; Gangur V; Simons FE; HayGlass KT
FASEB J; 2004 Feb; 18(2):329-31. PubMed ID: 14657006
[TBL] [Abstract][Full Text] [Related]
14. Systemic chemokine and chemokine receptor responses are divergent in allergic versus non-allergic humans.
Campbell JD; Stinson MJ; Simons FE; HayGlass KT
Int Immunol; 2002 Nov; 14(11):1255-62. PubMed ID: 12407016
[TBL] [Abstract][Full Text] [Related]
15. CCR3 blockade as a new therapy for asthma.
Bertrand CP; Ponath PD
Expert Opin Investig Drugs; 2000 Jan; 9(1):43-52. PubMed ID: 11060659
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031.
Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
Biochem Biophys Res Commun; 2006 Jan; 339(4):1217-23. PubMed ID: 16343433
[TBL] [Abstract][Full Text] [Related]
17. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.
Weber KS; Gröne HJ; Röcken M; Klier C; Gu S; Wank R; Proudfoot AE; Nelson PJ; Weber C
Eur J Immunol; 2001 Aug; 31(8):2458-66. PubMed ID: 11500830
[TBL] [Abstract][Full Text] [Related]
18. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Balashov KE; Rottman JB; Weiner HL; Hancock WW
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
[TBL] [Abstract][Full Text] [Related]
19. Turmeric (Curcuma longa) attenuates food allergy symptoms by regulating type 1/type 2 helper T cells (Th1/Th2) balance in a mouse model of food allergy.
Shin HS; See HJ; Jung SY; Choi DW; Kwon DA; Bae MJ; Sung KS; Shon DH
J Ethnopharmacol; 2015 Dec; 175():21-9. PubMed ID: 26342520
[TBL] [Abstract][Full Text] [Related]
20. Oral administration with diosgenin enhances the induction of intestinal T helper 1-like regulatory T cells in a murine model of food allergy.
Huang CH; Wang CC; Lin YC; Hori M; Jan TR
Int Immunopharmacol; 2017 Jan; 42():59-66. PubMed ID: 27886644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
